The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33
Open accessAbstract
BACKGROUND: The mechanism underlying severe asthma with fungal sensitization (SAFS) is unknown. IL-33 is important in fungus-induced asthma exacerbations, but its role in fungal sensitization is unexplored. OBJECTIVE: We sought to determine whether fungal sensitization in children with severe therapy-resistant asthma is mediated by IL-33. METHODS: Eighty-two children (median age, 11.7 years; 63% male) with severe therapy-resistant asthma were included. SAFS (n = 38) was defined as specific IgE or skin prick test response positivity to Aspergillus fumigatus, Alternaria alternata, or Cladosporium herbarum. Clinical features and airway immunopathology were assessed. Chronic exposure to house dust mite and A alternata were compared in a neonatal mouse model. RESULTS: Children with SAFS had earlier symptom onset (0.5 vs 1.5 years, P = .006), higher total IgE levels (637 vs 177 IU/mL, P = .002), and nonfungal inhalant allergen-specific IgE. Significantly more children with SAFS were prescribed maintenance oral steroids (42% vs 14%, P = .02). SAFS was associated with higher airway IL-33 levels. In neonatal mice A alternata exposure induced higher serum IgE levels, pulmonary IL-33 levels, and IL-13(+) innate lymphoid cell (ILC) and TH2 cell numbers but similar airway hyperresponsiveness (AHR) compared with those after house dust mite exposure. Lung IL-33 levels, IL-13(+) ILC numbers, TH2 cell numbers, IL-13 levels, and AHR remained increased with inhaled budesonide during A alternata exposure, but all features were significantly reduced in ST2(-/-) mice lacking a functional receptor for IL-33. CONCLUSION: Pediatric SAFS was associated with more oral steroid therapy and higher IL-33 levels. A alternata exposure resulted in increased IL-33-mediated ILC2 numbers, TH2 cell numbers, and steroid-resistant AHR. IL-33 might be a novel therapeutic target for SAFS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development of the asthma control test
Nathan, R. A., Sorkness, C. A., Kosinski, M., Schatz, M., Li, J. T., Marcus, P., Murray, J. J., & Pendergraft, T. B. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.09.008 · Cited by 2,906
O'Hollaren, M. T., Yunginger, J. W., Offord, K. P., Somers, M. J., O'Connell, E. J., Ballard, D. J., & Sachs, M. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102073240602 · Cited by 694
Bartemes, K. R., Iijima, K., Kobayashi, T., Kephart, G. M., McKenzie, A. N., & Kita, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102832 · Cited by 549
Fungal allergy in asthma-state of the art and research needs
Denning, D. W., Pashley, C., Hartl, D., Wardlaw, A., Godet, C., Del Giacco, S., Delhaes, L., & Sergejeva, S. (2014) · Clinical and Translational Allergy · doi:10.1186/2045-7022-4-14 · Cited by 357
IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma
Saglani, S., Lui, S., Ullmann, N., Campbell, G. A., Sherburn, R. T., Mathie, S. A., Denney, L., Bossley, C. J., Oates, T., Walker, S. A., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.04.012 · Cited by 258
Self-citationO'Driscoll, B. R., Hopkinson, L. C., & Denning, D. W. (2005) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-5-4 · Cited by 254
Marinho, S., Simpson, A., Söderström, L., Woodcock, A., Ahlstedt, S., & Custovic, A. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01502.x · Cited by 81
Cited by
Lambrecht, B. N., Hammad, H., & Fahy, J. V. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.018 · Cited by 1,039
Environmental exposures and mechanisms in allergy and asthma development
Murrison, L. B., Brandt, E. B., Myers, J. B., & Hershey, G. K. K. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124612 · Cited by 391
Perinatal Activation of the Interleukin-33 Pathway Promotes Type 2 Immunity in the Developing Lung
de Kleer, I. M., Kool, M., de Bruijn, M. J. W., Willart, M., van Moorleghem, J., Schuijs, M. J., Plantinga, M., Beyaert, R., Hams, E., Fallon, P. G., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.031 · Cited by 341
HpARI protein secreted by a helminth parasite suppresses interleukin-33
Osbourn, M., Soares, D. C., Vacca, F., Cohen, E. S., Scott, I. C., Gregory, W. F., Smyth, D. J., Toivakka, M., Kemter, A. M., le Bihan, T., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.09.015 · Cited by 178
Alternative splicing of interleukin-33 and type 2 inflammation in asthma
Gordon, E. D., Simpson, L. J., Rios, C. L., Ringel, L., Lachowicz-Scroggins, M. E., Peters, M. C., Wesolowska-Andersen, A., Gonzalez, J. R., MacLeod, H. J., Christian, L. S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601914113 · Cited by 153
Metadata
- Authors
- Castanhinha, S., Sherburn, R., Walker, S., Gupta, A., Bossley, C. J., Buckley, J., Ullmann, N., Grychtol, R., Campbell, G., Maglione, M., Koo, S., Fleming, L., Gregory, L., Snelgrove, R. J., Bush, A., Lloyd, C. M., & Saglani, S.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 136
- Issue
- 2
- Pages
- 312-322.e7
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2035843919
- Cited by
- 206
- References
- 7
- FWCI
- 11.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33. https://app.cochat.ai/papers/10.1016/j.jaci.2015.01.016
- The paper
- Castanhinha, S., Sherburn, R., Walker, S., Gupta, A., Bossley, C. J., Buckley, J., Ullmann, N., Grychtol, R., Campbell, G., Maglione, M., Koo, S., Fleming, L., Gregory, L., Snelgrove, R. J., Bush, A., Lloyd, C. M., & Saglani, S. (2015). Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2015.01.016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.